October 21, 2016 7:52 PM ET


Company Overview of Capricor Therapeutics, Inc.

Executive Profile

Earl M. Collier Jr., J.D., Esq.

Director and Chairman of Nominating & Corporate Governance Committee, Capricor Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 16 different industries.

See Board Relationships


Mr. Earl M. Collier Jr., also known as Duke, J.D., Esq., served as the Chief Executive Officer at 480 Biomedical, Inc. served from 2010 to 2014. Mr. Collier served as Part-Time Senior Advisor at Genzyme Corporation since October 2009 and served as its Executive Vice President from July 1997 to October 2009. He has more than 30 years of experience in healthcare. He served as Senior Advisor at Polaris Partners. He served as the Chief Executive Officer and Executive Chairman ...

Corporate Headquarters

8840 Wilshire Boulevard
Beverly Hills, California 90211

United States

Phone: 310-358-3200
Fax: --

Board Members Memberships

Independent Director
Director and Chairman of Nominating & Corporate Governance Committee
Independent Director, Chairman of Governance & Nominating Committee and Member of Compensation Committee


Yale University
University of Virginia School of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$27,877

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Robin C. Stracey Chief Executive Officer, President and Director
Cesca Therapeutics Inc.
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
Mike Tomas Chief Executive Officer, President, Chief Financial Officer and Director
U.S. Stem Cell, Inc.
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
Christian Homsy M.D., MBAChief Executive Officer and Executive Director
Celyad SA
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capricor Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.